Total Funding
31
43
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
83576
Woolsey Pharmaceuticals specializes in reinventing ways to treat some of the world’s most challenging diseases.
- Sven M. Jacobson: Co-Founding Partner & Chief Executive Officer
- David M. Geliebter: Co-Founder & Executive Chairman
About the Company
Woolsey Pharmaceuticals is a pharmaceutical company that specializes in reinventing ways to treat some of the world’s most challenging diseases. The company's approach allows them to accelerate the delivery of medicines for the benefit of all humankind.
The company was founded in 2019 and is headquartered in New York, United States.
